1-2 of 2
Barbara L. Asselin
Close
Sort by
Journal Articles

Refining risk classification in childhood B acute lymphoblastic leukemia: results of DFCI ALL Consortium Protocol 05-001

Clinical Trials & Observations
Lynda M. Vrooman, Traci M. Blonquist, Marian H. Harris, Kristen E. Stevenson, Andrew E. Place, Sarah K. Hunt, Jane E. O’Brien, Barbara L. Asselin, Uma H. Athale, Luis A. Clavell, Peter D. Cole, Kara M. Kelly, Caroline Laverdiere, Jean-Marie Leclerc, Bruno Michon, Marshall A. Schorin, Maria Luisa Sulis, Jennifer J. G. Welch, Donna S. Neuberg, Stephen E. Sallan, Lewis B. Silverman
Journal: Blood Advances
Blood Adv (2018) 2 (12): 1449–1458.
https://doi.org/10.1182/bloodadvances.2018016584
Published: 2018
Includes: Supplemental data
Journal Articles

Prognostic impact of kinase-activating fusions and IKZF1 deletions in pediatric high-risk B-lineage acute lymphoblastic leukemia

Clinical Trials & Observations
Thai Hoa Tran, Marian H. Harris, Jonathan V. Nguyen, Traci M. Blonquist, Kristen E. Stevenson, Eileen Stonerock, Barbara L. Asselin, Uma H. Athale, Luis A. Clavell, Peter D. Cole, Kara M. Kelly, Caroline Laverdiere, Jean-Marie Leclerc, Bruno Michon, Marshall A. Schorin, Jennifer J. G. Welch, Shalini C. Reshmi, Donna S. Neuberg, Stephen E. Sallan, Mignon L. Loh, Lewis B. Silverman
Journal: Blood Advances
Blood Adv (2018) 2 (5): 529–533.
https://doi.org/10.1182/bloodadvances.2017014704
Published: 2018